scholarly journals A rare case of quadricuspid aortic valve with moderate aortic regurgitation with left ventricular non compaction presenting with ventricular tachycardia

2018 ◽  
Vol 2 (2) ◽  
pp. 127-130
Author(s):  
Arnab Ghosh Chaudhury ◽  
B. Prabhavathi ◽  
C.N. Manjunath
Keyword(s):  
Ventricular Tachycardia ◽  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Rare Case ◽  
Left Ventricular ◽  
Quadricuspid Aortic Valve

scholarly journals Type F Congenital Quadricuspid Aortic Valve: A Very Rare Case Diagnosed by 3-dimenional Transoesophageal Echocardiography

2014 ◽  
Vol 8 (1) ◽  
pp. 23-25 ◽  
Author(s):  
Pankaj Garg ◽  
Hazlyna Kamaruddin ◽  
Rachel Orme ◽  
Victoria Watt
Keyword(s):  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Rare Case ◽  
Transoesophageal Echocardiography ◽  
Anatomical Variations ◽  
Cardiac Anomaly ◽  
Quadricuspid Aortic Valve ◽  
Transthoracic Echocardiogram ◽  
Shortness Of Breath ◽  
Rare Type

Congenital quadricuspid aortic valve (QAV) is a rare cardiac anomaly. Several different anatomical variations of a quadricuspid aortic valve have been described. Aortic regurgitation is the predominant valvular dysfunction associated with QAV and patients tend to present in their 5th or 6th decade of life. This anomaly is rarely picked up by transthoracic echocardiogram (TTE). A comprehensive transoesophageal echocardiography (TOE) study is more likely to diagnose it. We describe a very rare type of QAV – Type F in a 52-year-old lady who presented with symptoms of shortness of breath and pre-syncope. We include TOE images and intra-operative valve images.

scholarly journals Trans-apical aortic valve implantation for quadricuspid aortic valve with aortic regurgitation using J-valve system: a case reports

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Chaodi Luo ◽  
Yi Jiang ◽  
Qiang Chen ◽  
Yang Yan ◽  
Dan Han
Keyword(s):  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Case Reports ◽  
Left Ventricular ◽  
Quadricuspid Aortic Valve ◽  
Valve System ◽  
First Case ◽  
Valve Insufficiency ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Background Quadricuspid aortic valve (QAV) is a rare congenital heart defect usually accompanied with different hemodynamic abnormalities. Due to the rarity of QAV, treatment and prognosis of QAV patients with aortic regurgitation still remain challenging. We here present the first case of a patient with severe QAV regurgitation who underwent successful treatment and performed favorable prognosis with transapical aortic valve implantation (TAVI) using J-Valve system. Case presentation A 62-year-old man experienced intermittent palpitation, shortness of breath and chest pain. Echocardiography revealed congenital QAV with massive aortic regurgitation and mild aortic stenosis, left ventricular enlargement. Aortic valve replacement was successfully performed with TAVI using J-Valve system. The postoperation and follow-up was uneventful. Conclusion TAVI using J-Valve system has emerged as a new high success rate method for treatment of patients with simple non-calcified aortic valve insufficiency.

scholarly journals Trans-apical Aortic Valve Implantation for Quadricuspid Aortic Valve With Aortic Regurgitation Using J-valve System: A Case Report

2021 ◽  
Author(s):  
Chaodi Luo ◽  
Yi Jiang ◽  
Yang Yan ◽  
Dan Han
Keyword(s):  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Left Ventricular ◽  
Quadricuspid Aortic Valve ◽  
Valve System ◽  
First Case ◽  
Valve Insufficiency ◽  
Risk Patients ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Background: Quadricuspid aortic valve (QAV) is a rare congenital heart defect usually accompanied with different hemodynamic abnormalities. Due to the rarity of QAV, treatment and prognosis of QAV patients with aortic regurgitation still remain challenging. We here present the first case of a patient with severe QAV regurgitation who underwent successful treatment and performed favorable prognosis with transapical aortic valve implantation (TAVI) using J-Valve system.Case presentation: A 62-year-old man experienced intermittent palpitation, shortness of breath and chest pain. Echocardiography revealed congenital QAV with massive aortic regurgitation and mild aortic stenosis, left ventricular enlargement. Aortic valve replacement was successfully performed with TAVI using J-Valve system. The postoperation and follow-up was uneventful.Conclusion: Transapical aortic valve implantation (TAVI) using J-Valve system has emerged as a new high success rate method for treatment of high-risk patients with simple non-calcified aortic valve insufficiency.

scholarly journals WCC 2017-C-109: Congenital Quadricuspid Aortic Valve Associated with Severe Aortic Regurgitation: A Rare Case Report

2017 ◽  
Vol 02 (S 01) ◽  
pp. S13-S15
Author(s):  
Pavaneel Bhandary ◽  
Palanki Satyagopal ◽  
Muppiri Kumar ◽  
Ravinuthala Kumar
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Male Patient ◽  
Rare Case ◽  
Aortic Insufficiency ◽  
Quadricuspid Aortic Valve ◽  
Severe Aortic Regurgitation ◽  
Rare Case Report

AbstractQuadricuspid aortic valve is a very rare congenital valvular anomaly. Most of these cases present with aortic insufficiency. We present a 38 year old male patient with aquadricuspid aortic valve with severe aortic regurgitation.

A case of quadricuspid aortic valve with severe aortic regurgitation diagnosed by transthoracic echocardiography

Choonpa Igaku ◽  
2011 ◽  
Vol 38 (4) ◽  
pp. 461-464
Author(s):  
Koutatsu NOMURA ◽  
Yoshikazu YAZAKI ◽  
Masako MIYASHITA ◽  
Sachiko OOTSUKI ◽  
Yutaka KUMAGAI ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Transthoracic Echocardiography ◽  
Quadricuspid Aortic Valve ◽  
Severe Aortic Regurgitation

scholarly journals An Exceedingly Rare Case of Concomitant Quadricuspid Aortic Valve and Atrial Myxoma

2021 ◽  
Vol 3 (2) ◽  
pp. 267-268
Author(s):  
Elodie Deschamps ◽  
Nicolas Piliero ◽  
Hélène Bouvaist ◽  
Paolo Porcu ◽  
Pierre-Vladimir Ennezat
Keyword(s):  
Aortic Valve ◽  
Rare Case ◽  
Atrial Myxoma ◽  
Quadricuspid Aortic Valve

Presence of adipose tissue in aortic valves from aortic regurgitation patients: pathophysiological role and clinical implications

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
A Sadaba Cipriain ◽  
A.M Navarro Echeverria ◽  
C.R Tiraplegui Garjon ◽  
A Garcia De La Pena Urtasun ◽  
V Arrieta Paniagua ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Aortic Valve ◽  
Aortic Regurgitation ◽  
Systolic Function ◽  
Statistical Significance ◽  
Left Ventricular Systolic Function ◽  
Left Ventricular ◽  
Funding Source ◽  
Matrix Remodeling ◽  
Aortic Valves

Abstract Introduction Adipose tissue is a common constituent of the heart and it is located, without great clinical relevance, frequently in the pericardium. The presence of adipose tissue in the aortic valve is rare, with unknown significance on valve structural properties and function. Aortic regurgitation (AR) is the third most prevalent valve disease, although it is uncommon to find it in isolation. Myxoid degeneration may be the cause or result of AR, although the pathophysiology remains poorly understood. Purpose To describe and characterize the presence of adipose tissue in the aortic valves from a cohort of AR patients. Methods 116 patients undergoing aortic valve replacement due to severe AR were enrolled. We classified them in two groups according to the histological results showing presence or absence of adipose tissue in the aortic valves. In the valve tissue molecular analysis were performed by RT-PCR, Western Blot and ELISA to analyze markers of adipocytes (leptin, adiponectin, resistin), inflammation (Rantes, interleukin-6, interleukin-1β), extracellular matrix remodeling (metalloproteinases-1, -2 and -9), proteoglycans (aggrecan, hyaluronan, lumican, syndecan-1, decorin) and fibrosis (collagens, fibronectin). Results Adipose tissue was found in 63% of the aortic valves analyzed. Baseline characteristics (age, hypertension, dyslipidemia, diabetes, smoking, left ventricular telediastolic diameter, left ventricular systolic function, ascending aorta) were similar in patients presenting valve adipose tissue as compared with patients without valve adipose tissue. Valves containing adipocytes exhibited a higher leptin content (p<0.001), fibronectin (p<0.01), decorin (p<0,0001), hyaluronan (p=0.03), aggrecan (p=0.04) and metalloproteinase 1 (p=0.03). Interestingly, the presence of adipocytes in the valve was positively correlated with valve thickness measured by echocardiogram (Pearson chi2 statistical significance = 26.3345 p<0.001). Conclusion To our knowledge, this is the first study that describes the presence of adipose cells in aortic valves from a cohort of AR patients. Aortic valves containing adipocytes were thicker and exhibited significant higher levels of proteoglycans, suggesting that adipocytes could contribute to the myxomatous degeneration process. Our results propose that the valve adipose tissue could play a role in the pathophysiology of AR. Funding Acknowledgement Type of funding source: Public hospital(s). Main funding source(s): Gobierno de Navarra

Sign in / Sign up

Export Citation Format

Share Document